2026 CMS Program Audit Update: What Plans Must Do To Align
What Changed for 2026: Key Updates from CMS The 2026 audit update from CMS brings a fundamental shift in audit […]
Regulatory Compliance
CMS Policy Brief on AI for Payers
CMS Sets New Guardrails for AI in Medicare Advantage The New Regulatory Landscape: CMS Guidance on AI and Algorithms While
2026 CMS Program Audit Countdown: How Health Plans Can Prepare Now
The audit clock has already started CMS Program Audits follow predictable patterns, but most health plans still treat them as
How Disaster Declarations and Emergency Waivers Impact Health Plans
How automation protects compliance, revenue, and member trust For health plans, disasters don’t just test emergency response; they test compliance,
Top 7 Compliance Gaps That Put Health Plans at Risk
Compliance gaps are costing more than just fines CMS Program Audits are not just a regulatory formality, they are high-stakes
CMS-0057-F Final Rule: How Health Plans Can Prepare for Prior Authorization Reform
CMS-0057-F is reshaping how health plans handle prior authorization, data sharing, and compliance transparency. This guide breaks down what’s changing, what’s at risk, and how payers can prepare to meet the 2026–27 mandates with confidence.
Simplifying Prior Authorization Processes in HealthcareÂ
CMS’s comprehensive updates focus on improving beneficiary access, promoting transparency, and streamlining PA processes. Here’s what you need to know
Medicare Prescription Payment Plan (M3P) Implementation: Key Considerations for Part D Plan Sponsors and PBMs
The upcoming Medicare Prescription Payment Plan (M3P), set to launch in January 2025, marks a significant shift in Medicare’s approach
Streamlining Medicare Advantage Organizations Member Communication: A Guide to CMS’s Model Materials for CY 2025
Every year, Medicare Advantage Organizations (MAO)1 must update their member communication materials, such as the Annual Notice of Change (ANOC),
Ensuring Accurate Drug Claims: Insights from CMS Audits and Best Practices
The Centers for Medicare & Medicaid Services (CMS) has added another category of drugs—immunosuppressants—to their national audits in collaboration with